| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907645 | Experimental Hematology | 2005 | 7 Pages |
Abstract
These results suggest that carefully scheduled drug combinations that include an agent to antagonize the anti-proliferative effect of IM may prove more efficacious within the Ph+ stem cell compartment than IM monotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Heather G. Jørgensen, Elaine K. Allan, Joanne C. Mountford, Linda Richmond, Simon Harrison, Moira A. Elliott, Tessa L. Holyoake,